Penta Valent is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1968. Penta Valent, a prominent player in the Indonesian pharmaceutical industry, was founded by visionary entrepreneurs who aimed to enhance healthcare accessibility in the region. The company specializes in the production and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. With a strong local presence, Penta Valent operates several branches across Indonesia, ensuring that its products are readily available to a broad customer base. The company is known for its commitment to quality and innovation, continuously investing in research and development to introduce new and effective healthcare solutions. Penta Valent's product portfolio includes well-known brands that cater to various therapeutic areas, such as cardiovascular health, respiratory care, and pain management. The company has also established strategic partnerships with international pharmaceutical firms to expand its product offerings and enhance its market reach. In addition to its domestic operations, Penta Valent exports its products to several countries in Southeast Asia, contributing to the region's healthcare landscape. The company is a member of various industry associations, actively participating in initiatives to improve healthcare standards and regulations. Penta Valent's mission is to improve the quality of life through accessible and affordable healthcare solutions. The company envisions becoming a leading pharmaceutical provider in Asia, driven by its core values of integrity, innovation, and customer satisfaction.
Headquarters
Jl. Kedoya Raya No.33 RT. 002 RW. 007
West Jakarta; Jakarta;
Postal Code: 11520
Contact Details: Purchase the Pt Penta Valent report to view the information.
Website: http://pentavalent.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service